Corporate capital and (de)monopolization of public health in the USA : an institutionalist perspective
Year of publication: |
2022
|
---|---|
Authors: | Josifidis, Kosta ; Supic, Novica |
Published in: |
Journal of economic issues. - Abingdon, Oxon : Routledge, Taylor & Francis, ISSN 1946-326X, ZDB-ID 2066505-2. - Vol. 56.2022, 2, p. 378-386
|
Subject: | corporate capital | Original Institutional Economics | pharmaceutical industry | public health | USA | Institutionenökonomik | Institutional economics | United States | Gesundheitswesen | Health care system | Kapitalismus | Capitalism | Pharmaindustrie | Pharmaceutical industry | Gesundheitspolitik | Health policy |
-
Sarnoff, Joshua D., (2020)
-
The business of health : the role of competition, markets, and regulation
Ohsfeldt, Robert L., (2006)
-
American health care : government, market processes, and the public interest
Feldman, Roger D., (2000)
- More ...
-
Social spending (in)efficiency of the European welfare regimes in reducing poverty
Josifidis, Kosta, (2010)
-
Labour migration flows : EU8+2 vs EU-15
Josifidis, Kosta, (2014)
-
The welfare regimes and relative poverty in the EU-14 : 1995 - 2006
Josifidis, Kosta, (2012)
- More ...